Article PDF
Avoid common mistakes on your manuscript.
References
Lemieux S, Després J, Moorjani S et al. (1994) Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia 37: 757–764
Chaturvedi N, McKeigue P, Marmot M (1994) Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 37: 765–772
Ernst E (1990) Plasma fibrinogen — an independent cardiovascular risk factor. J Int Med 227: 365–372
Heinrich J, Balleisen F, Schulte H, Assmann G, van de Loo J (1994) Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arteriosclerosis Thrombosis 14: 54–59
Stensvold I, Tverdahl A, Urdal P, Graff-Iversen S (1993) Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middleaged Norwegian women. BMJ 307: 1318–1322
Bengtsson, Björkelund C, Lapidus L, Lissner L (1993) Association of serum lipid concentration and obesity with mortality in women: 20 year follow-up of participants in a prospective population study in Gothenburg, Sweden. BMJ 307: 1385–1388
LindenstrØm E, Boysen G, Nyboe J (1994) Influence of total cholesterol, HDL-cholesterol and triglycerides on cardiovascular risk: the Copenhagen city heart study. BMJ 309: 11–15
References
Gillman T, Naidoo SS, Hathorn M (1957) Fat, fibrinolysis, and atherosclerosis in Africans. Lancet II: 696–697
Franz RC, Kark AE, Hathorn M (1961) Postoperative thrombosis and plasma fibrinolytic activity. A comparative study in Africans, Indians and Whites. Lancet I: 195–197
Barr RD, Ouna N, Kendall AG (1973) The blood coagulation and fibrinolytic enzyme systems in healthy adult Africans and Europeans — a comparative study. Scot Med J 18: 93–97
Dischinger P, Tyroler HA, McDonagh R Jr, Hames CG (1980) Blood fibrinolytic activity, social class and habitual physical activity. A study of black and white men in Evans County, Georgia. J Chronic Dis 33: 283–290
Meade TW, Stirling Y, Thompson SG et al. (1986) An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group. Int J Epidemiol 15: 331–336
Meade TW, Brozovic M, Chakrabarti R, Haines AP, North WRS, Stirling Y (1978) Ethnic group comparisons of variables associated with ischaemic heart disease. Br Heart J 40: 789–795
Brunner EJ, Marmot MG, White IR et al. (1993) Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis 102: 195–207
Meade TW, Brozovic M, Chakrabarti RR et al. (1986) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet II: 533–537
References
Lemieux S, Després J-P, Moorjani S et al. (1994) Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia 37: 757–764
Francis RB, Kawanishi D, Baruch T, Mahrer P, Rahimtoola S, Feinstein DI (1988) Impaired fibrinolysis in coronary artery disease. Am Heart J 115: 776–780
Olofsson BO, Dahlen G, Nilsson TK (1989) Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J 10: 77–82
Vague P, Juhan-Vague I, Aillaud MF et al. (1986) Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35: 250–253
Vague P, Juhan-Vague I, Chabert V, Alessi MC, Atlan C (1989) Fat distribution and plasminogen activator inhibitor activity in non-diabetic obese women. Metabolism 38: 913–915
Juhan-Vage I, Alessi MC, Vague P (1991) Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34: 457–462
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
DeFronzo RA, Ferrannini E (1991) Multifaceted syndrome response for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194
Ernst E et al. (1990) Plasma fibrinogen — an independent cardiovascular risk factor. J Int Med 227: 365–372
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Breimer, L., Chaturvedi, N. & Després, J.P. Plasma fibrinogen as cardiovascular risk factor. Diabetologia 38, 630–631 (1995). https://doi.org/10.1007/BF00400736
Issue Date:
DOI: https://doi.org/10.1007/BF00400736